Gilead Sciences is an American biotechnology company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, hepatitis B or influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with pulmonary diseases. The company has fourteen commercially available products. Headquartered and founded in Foster City, California, Gilead has operations in North America, Europe and Australia. As of the end of 2009, the company had... approximately 4,000 full-time employees. The company's name and logo refer to the Balm of Gilead. Gilead was famed for its small trees that produced a resin used in medicine. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500. Gilead Sciences was originally formed at Menlo Ventures under the name of "Oligogen, Inc." in August 1987 by H. DuBose Montgomery, co-founder of Menlo Ventures and Michael L. Riordan, a medical doctor who was 29 years old at the time.
more
| NASDAQ symbol: | GILD |
| Founded: | 1987 |
| Headquarters: | Foster City, California |
| Annual revenue: | $5,335,750,000 |
| Net income: | $2,011,150,000 |
| Operating income: | $2,678,540,000 |
| Market cap: | $43,000,000,000 |
| Employees: | 2,515 |
| Industries: | Health care, Biotechnology, Pharmaceutical industry, Biological Product (except Diagnostic) Manufacturing |